Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are recognized for their tumor-suppressive roles in cancer.
• The specific function of miR-325-3p in non-small cell lung cancer (NSCLC) remains largely uncharacterized.
• High-mobility group box 1 (HMGB1) is implicated in various cancers.

Purpose of the Study:

• To investigate the role of miR-325-3p in NSCLC.
• To determine the relationship between miR-325-3p and HMGB1 in NSCLC.
• To evaluate miR-325-3p as a potential prognostic biomarker for NSCLC patients.

Main Methods:

• Analysis of miR-325-3p and HMGB1 expression in 107 NSCLC patient samples.
• In vitro assays (Transwell, CCK-8) to assess cell invasion and proliferation upon miR-325-3p modulation.
• Bioinformatic analysis to predict the regulatory relationship between miR-325-3p and HMGB1.

Main Results:

• miR-325-3p was found to be downregulated, while HMGB1 was upregulated in NSCLC tissues.
• Inhibition of miR-325-3p promoted NSCLC cell invasion and proliferation.
• Upregulation of miR-325-3p suppressed NSCLC cell invasion and proliferation.
• HMGB1 was identified as a direct and negatively regulated target of miR-325-3p.
• Low miR-325-3p expression was associated with a poor prognosis in NSCLC patients.

Conclusions:

• miR-325-3p functions as a tumor suppressor in NSCLC by targeting HMGB1.
• The miR-325-3p/HMGB1 axis plays a crucial role in regulating NSCLC cell invasion and proliferation.
• miR-325-3p holds promise as a valuable prognostic biomarker for NSCLC.